Axert

Axert is a brand name of almotriptan, approved by the FDA in the following formulation(s):

AXERT (almotriptan malate - tablet; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: May 7, 2001
  
  Strength(s): EQ 12.5MG BASE ^[RLD], EQ 6.25MG BASE
  

Has a generic version of Axert been approved?

No. There is currently no therapeutically equivalent version of Axert available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Axert. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Indole derivatives
  Patent 5,565,447
  Issued: October 15, 1996
  Inventor(s): Forner; Dolors F. & Duran; Carles P. & Soto; Jose P. & Noverola; Armando V. & Mauri; Jacinto M.
  Assignee(s): Laboratorios Almirall S.A.
  A compound of formula (I) ##STR1## wherein R.sup.1 and R.sup.2 each represents a hydrogen atom or an alkyl group, Z represents a ring selected from: ##STR2## in which n represents 4, 5 or 6; ##STR3## in which R.sup.3 represents hydrogen or an alkyl group and R.sup.4 represents an alkyl, methoxy benzyl or R.sup.5 NHCO group, R.sup.5 being an alkyl group; and ##STR4## in which R.sup.6 represents an alkyl group. and pharmaceutically acceptable salts thereof are useful in the treatment of migraine and other conditions. They are prepares by decarboxylation of the corresponding indolyl 2-carboxylic acid.
  
  Patent expiration dates:
  
  
  • May 7, 2015
    
    ✓ 
    Patent use: TREATMENT OF MIGRAINE
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • November 7, 2015
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Axert Consumer Information (Wolters Kluwer)
• Axert Consumer Information (Cerner Multum)
• Axert Advanced Consumer Information (Micromedex)
• Axert AHFS DI Monographs (ASHP)
• Almotriptan Consumer Information (Wolters Kluwer)
• Almotriptan Consumer Information (Cerner Multum)
• Almotriptan Advanced Consumer Information (Micromedex)
• Almotriptan Malate AHFS DI Monographs (ASHP)